Vaneck Pharmaceutical Etf Profile

PPH Etf  USD 92.64  0.73  0.78%   

Performance

OK

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
VanEck Pharmaceutical is trading at 92.64 as of the 22nd of March 2025. This is a 0.78 percent decrease since the beginning of the trading day. The etf's open price was 93.37. VanEck Pharmaceutical has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Pharmaceutical is traded on NASDAQ Exchange in the United States. More on VanEck Pharmaceutical ETF

Moving together with VanEck Etf

  0.81XLV Health Care SelectPairCorr
  0.71VHT Vanguard Health CarePairCorr
  0.87IXJ iShares Global HealthcarePairCorr

Moving against VanEck Etf

  0.5XBI SPDR SP BiotechPairCorr
  0.34SIXD AIM ETF ProductsPairCorr

VanEck Etf Highlights

Thematic Ideas
(View all Themes)
Old Names[Pushpay Holdings Ltd, Phong Phu Corp, Vaneck Vectors Pharmaceutical Etf]
Business ConcentrationHealth Care ETFs, Sector ETFs, Health, VanEck (View all Sectors)
IssuerVan Eck
Inception Date2011-12-20
BenchmarkMarket Vectors US Listed Pharmaceutical 25 Index
Entity TypeRegulated Investment Company
Asset Under Management632.62 Million
Average Trading Valume270,819
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionGlobal
AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianState Street Bank and Trust Company
DistributorVan Eck Securities Corporation
Portfolio ManagerHao-Hung Peter Liao, Guo Hua Jason Jin
Transfer AgentState Street Bank and Trust Company
Fiscal Year End30-Apr
ExchangeNASDAQ
Number of Constituents25.0
Market MakerIMC
Total Expense0.36
Management Fee0.35
Country NameUSA
Returns Y T D8.22
NameVanEck Pharmaceutical ETF
Currency CodeUSD
Open FigiBBG000BCKT22
In Threey Volatility13.89
1y Volatility13.04
200 Day M A91.9407
50 Day M A90.1112
CodePPH
Updated At21st of March 2025
Currency NameUS Dollar
VanEck Pharmaceutical ETF [PPH] is traded in USA and was established 2011-12-20. The fund is classified under Health category within VanEck family. The entity is thematically classified as Health Care ETFs. VanEck Pharmaceutical ETF at this time have 530.46 M in assets. , while the total return for the last 3 years was 7.7%.
Check VanEck Pharmaceutical Probability Of Bankruptcy

Geographic Allocation (%)

Top VanEck Pharmaceutical ETF Etf Constituents

ABBVAbbVie IncStockHealth Care
BMYBristol Myers SquibbStockHealth Care
JNJJohnson JohnsonStockHealth Care
LLYEli Lilly andStockHealth Care
MCKMcKessonStockHealth Care
MRKMerck CompanyStockHealth Care
NVONovo Nordisk ASStockHealth Care
NVSNovartis AG ADRStockHealth Care
More Details

VanEck Pharmaceutical ETF Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in VanEck Pharmaceutical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

VanEck Pharmaceutical Against Markets

When determining whether VanEck Pharmaceutical ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Pharmaceutical Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Pharmaceutical Etf:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in VanEck Pharmaceutical ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
The market value of VanEck Pharmaceutical ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is VanEck Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Pharmaceutical's market value can be influenced by many factors that don't directly affect VanEck Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.